References
1. Armstrong GT, Chen Y, Yasui Y, et al. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. N Engl J Med 2016:374(9):833-842.
2. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 2014:14(1):61-70.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006:355(15):1572-1582.
4. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013:309(22):2371-2381.
5. Turcotte LM, Yingst A, Verneris MR. Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction. Biol Blood Marrow Transplant 2016:22(7):1159-1166.
6. Oudin C, Auquier P, Bertrand Y, et al. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. Bone Marrow Transplant 2015:50(11):1438-1444.
7. Smith WA, Li C, Nottage KA, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer 2014:120(17):2742-2750.
8. Rosen GP, Nguyen HT, Shaibi GQ. Metabolic syndrome in pediatric cancer survivors: a mechanistic review. Pediatr Blood Cancer 2013:60(12):1922-1928.
9. Paris C, Yates L, Lama P, et al. Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents. Pediatr Blood Cancer 2012:59(2):306-310.
10. Baker KS, Chow E, Steinberger J. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012:47(5):619-625.
11. Oudin C, Simeoni MC, Sirvent N, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 2011:117(17):4442-4448.
12. van Waas M, Neggers SJ, Pieters R, et al. Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol 2010:21(5):1121-1126.
13. de Haas EC, Oosting SF, Lefrandt JD, et al. The metabolic syndrome in cancer survivors. Lancet Oncol 2010:11(2):193-203.
14. Majhail NS, Flowers ME, Ness KK, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2009:43(1):49-54.
15. Talvensaari KK, Lanning M, Tapanainen P, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996:81(8):3051-3055.
16. Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 2010:2010.
17. Ariffin H, Azanan MS, Abd Ghafar SS, et al. Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging. Cancer 2017:123(21):4207-4214.
18. Chua LL, Rajasuriar R, Azanan MS, et al. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome 2017:5(1):35.
19. Rotz SJ, Dandoy CE. The microbiome in pediatric oncology. Cancer 2020.
20. Chua LL, Rajasuriar R, Lim YAL, et al. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer 2020:20(1):151.
21. Hakim H, Dallas R, Wolf J, et al. Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia. Clin Infect Dis 2018:67(4):541-548.
22. Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther 2015:42(5):515-528.
23. Gasparrini AJ, Wang B, Sun X, et al. Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol 2019:4(12):2285-2297.
24. Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 2016:7:10410.
25. Yassour M, Vatanen T, Siljander H, et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 2016:8(343):343ra381.
26. Saari A, Virta LJ, Sankilampi U, et al. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 2015:135(4):617-626.
27. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009:457(7228):480-484.
28. Sun S, Lulla A, Sioda M, et al. Gut Microbiota Composition and Blood Pressure. Hypertension 2019:73(5):998-1006.
29. Org E, Blum Y, Kasela S, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol 2017:18(1):70.
30. Green DM, Nolan VG, Goodman PJ, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2014:61(1):53-67.
31. Sinha R, Abnet CC, White O, et al. The microbiome quality control project: baseline study design and future directions. Genome biology 2015:16:276.
32. Hall M, Beiko RG. 16S rRNA Gene Analysis with QIIME2. Methods Mol Biol 2018:1849:113-129.
33. Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods 2016:13(7):581-583.
34. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013:8(4):e61217.
35. Beals EW. Bray-Curtis Ordination: An Effective Strategy for Analysis of Multivariate Ecological Data. In: MacFadyen A, Ford ED, editors. Advances in Ecological Research. Volume 14: Academic Press; 1984. p 1-55.
36. Wickham H. ggplot2: Elegant Graphics for Data Analysis: Springer Publishing Company, Incorporated; 2009. 216 p.
37. White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 2009:5(4):e1000352.
38. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990:9(7):811-818.
39. Cozen W, Yu G, Gail MH, et al. Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins. Br J Cancer 2013:108(5):1163-1167.
40. Reis Ferreira M, Andreyev HJN, Mohammed K, et al. Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy. Clin Cancer Res 2019:25(21):6487-6500.
41. Sahly N, Moustafa A, Zaghloul M, et al. Effect of radiotherapy on the gut microbiome in pediatric cancer patients: a pilot study. PeerJ 2019:7:e7683.
42. Huseyin CE, O’Toole PW, Cotter PD, et al. Forgotten fungi-the gut mycobiome in human health and disease. FEMS Microbiol Rev 2017:41(4):479-511.
43. Mar Rodriguez M, Perez D, Javier Chaves F, et al. Obesity changes the human gut mycobiome. Sci Rep 2015:5:14600.